Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients ...Middle East

Patients will be able to enroll in trial at any time and regardless of failure from other therapeutics NEW YORK, Jan. 18, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, announced today that it has received U.S. Food and Drug...

Hence then, the article about hoth therapeutics announces it received fda approval to expand ht 001 clinical trial to treat severely ill patients was published today ( Thursday 18/01/2024 - 04:20 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients )

Also on site :

• Variety Announces Brand Entertainment for Fans  Event Spotlighting Leaders at Cannes Lions
• Sam’s Club is Selling a Giant Bag of Lucky Charms Marshmallows For Just $9–and There’s a Magical Surprise Inside
• G7 considering licensed arms production in Ukraine: Why now?